What is Chemical Works of Gedeon Richter PEG Ratio?
Chemical Works of Gedeon RichterRGEDF -1.78%94 PEG Ratio is 0.89 as of Jun. 28, 2026, which is 29% below its 10-year median of 1.26. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $36.19 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 346 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 72.54% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Chemical Works of Gedeon Richter's PEG Ratio or its related term are showing as below:
RGEDF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.13 Med: 1.26 Max: 963.69
Current: 0.9
During the past 13 years, Chemical Works of Gedeon Richter's highest PEG Ratio was 963.69. The lowest was 0.13. And the median was 1.26.
RGEDF's PEG Ratio is ranked better than 72.54% of 346
companies
in the Drug Manufacturers industry
Industry Median: 1.67
vs RGEDF: 0.90
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Chemical Works of Gedeon Richter (OTCPK:RGEDF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Chemical Works of Gedeon Richter PEG Ratio Related Terms
Chemical Works of Gedeon Richter PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemical Works of Gedeon Richter PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Chemical Works of Gedeon Richter's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Chemical Works of Gedeon Richter (RGEDF) has a PEG Ratio of 0.89 as of Jun. 28, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Chemical Works of Gedeon Richter and its competitors. This is 29% below median its historical median of 1.26. Over the past decade, Chemical Works of Gedeon Richter's PEG Ratio has ranged from 0.13 to 963.69. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #95 out of 346 companies in the Drug Manufacturers industry, placing it in the top 27.5%.
Is Chemical Works of Gedeon Richter's PEG Ratio too high?
Chemical Works of Gedeon Richter's current PEG Ratio of 0.89 is 29% below median its 10-year median of 1.26. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 963.69. The Drug Manufacturers industry median PEG Ratio is 1.67. Chemical Works of Gedeon Richter's value of 0.89 is 46.7% below this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #95 out of 346 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #95 out of 346 companies for PEG Ratio. This puts Chemical Works of Gedeon Richter in the upper half of its industry. The industry median PEG Ratio is 1.67. Chemical Works of Gedeon Richter's value of 0.89 is 46.7% below this benchmark. Historically, Chemical Works of Gedeon Richter's own PEG Ratio has ranged from 0.13 to 963.69 over the past decade. While the company's 10-year median is 1.26 vs. the industry median of 1.67, Chemical Works of Gedeon Richter has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.67, based on 346 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current PEG Ratio of 0.89 is 46.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current PEG Ratio is 0.89, which is 29% below median its own 10-year median of 1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $36.19, compared to a current price of $39.59 — trading 9.4% above its estimated fair value. The current PEG Ratio is 0.89, which is 29% below median its 10-year median of 1.26 and 46.7% below the Drug Manufacturers industry median of 1.67. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current PEG Ratio is 0.89 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued.
The current stock price of $39.59 is trading 9.4% above its estimated GF Value™ of $36.19.
GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.
Key valuation signals for RGEDF:
PEG Ratio: 0.89 (29% below median its 10-year median of 1.26)
GF Value™: $36.19 vs. price of $39.59 (9.4% above fair value)
Industry Position: 46.7% below the Drug Manufacturers median (#95 of 346)
No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemical Works of Gedeon Richter Business Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score
Get the complete analysis for RGEDF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGEDF has been successfully added to your 
